Bought
Maintained
Sold
Other funds holding EXPO
GCM
RA
CCA
Aviva's EXPO Position: Q2 2026 in Review
Aviva increased its Exponent (EXPO) stake by 18% in Q2 2026, buying an estimated $72.7K and bringing the position to 7,678 shares worth $451K. The position accounts for ﹤0.01% of the portfolio, ranked #755.
Aviva first reported a position in EXPO in Q4 2019 and has held it in 26 quarters since. The position peaked at $3.71M in Q1 2020. 341 funds tracked by Wall St. Rank hold EXPO as of Q2 2026.
- Aviva held 7,678 shares of Exponent worth $451K as of Q2 2026.
- Aviva bought 1,184 Exponent shares in Q2 2026, an estimated $72.7K.
- Exponent made up ﹤0.01% of Aviva's portfolio in Q2 2026, its #755 holding.
- Aviva first reported a position in Exponent in Q4 2019 and has held it in 26 quarters since.
- Aviva's Exponent position peaked at $3.71M in Q1 2020.
- 341 funds tracked by Wall St. Rank held Exponent as of Q2 2026.
Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.